X

Translational Bytes

Translational Bytes


Apr24 Drug Variability in Pediatric Epilepsy Treatment

With a wide variety of antiseizure medications (ASMs) available and the dynamic nature of children's physiology, ensuring effective therapy could present a challenge. As children grow and change, variables that influence drug disposition do as well. Body weight, age, drug interactions, formulation ...
Read More..

Feb28 Ever Wonder How We Can Best Understand Existing Drugs and Their Benefit to Patients?

We set out to evaluate the quality and precision of real-world observational studies (RWS) versus randomised controlled trials (RCTs). Any answer we found would have profound impact on the scientific community’s ability to respond quickly and well to future pandemics. With 249 study results from a ...
Read More..

Jan18 CTS: 2023 Year in Review, and Looking Forward to 2024!

Looking back at 2023,  CTS  has had a great year. One of our goals continues to be becoming a beacon for the field of translational science, fulfilling a major component of  ASCPT’s Strategic Plan .  In the spirit of a 2023 review, we wanted to celebrate our most impactful contributions.
Read More..

Jan11 Unlocking the Secrets of Drug Mechanisms: Introducing the CTS Mini-Review Series

The world of biopharmaceuticals is ever evolving, with groundbreaking drugs constantly being developed to combat a myriad of diseases. Understanding how these drugs work, their pharmacokinetics, and pharmacodynamics is crucial not just for healthcare professionals but especially for anyone with an ...
Read More..

Dec20 Tutorial on Data Management

In a tutorial from Clinical and Translational Science (CTS) entitled “Data Management 101 for drug developers: A peek behind the curtain”, my coauthors and I review the essentials of clinical data management. This tutorial is mainly for those who are new to drug development and assumes only a passi...
Read More..

Dec12 Getting Input From Experts and Patients for Pediatric Clinical Trials

In a  recent article published in  Clinical and Translational Science , Dhaenens  et al.  reported the results of a collaboration between two Innovative Medicines Initiative (IMI(2)) projects: the  Collaborative Network for European Clinical Trials for Children (conect4children, c4c) project...
Read More..

Nov20 Dexamethasone PK/PD in COVID-19

Dexamethasone has become an important element of COVID-19 treatment in patients requiring oxygen therapy. Our research reveals that daily doses of 6 or 12 mg dexamethasone for 10 days are required for substantial reductions in TNFα, IL-6, and CRP concentrations. This study not only reaffirms the cu...
Read More..

Nov01 Real-World Evidence for Phenoconversion

Clopidogrel, a widely prescribed antiplatelet medication, varies in its effectiveness due to multiple factors, including genetics and drug interactions. The CYP2C19 enzyme plays a key role in converting clopidogrel into its active form. Individuals carrying  CYP2C19  loss-of-function (LOF) allele...
Read More..

Oct16 Not Allergic to Immunotherapy

Allergic conditions such as asthma, chronic urticaria, atopic dermatitis, and eosinophilic esophagitis are widespread among the population. Often patients will have multiple concomitant allergic conditions, each requiring its own management strategy and specialist visits. During the last few decade...
Read More..

Oct09 Biomarkers in Mitochondrial Disorders: Separating Wheat From Chaff

Employing fit-for-purpose biomarkers in the earliest phases of drug development can advance rational clinical development of drug candidates. Identifying the right biomarker(s) for this task is crucial, especially in mitochondrial disorders—diseases characterized by substantial heterogeneity, both ...
Read More..
Photo Gallery
Recent News
Contact Us